<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">
Blogs

Colorado Clinical and Translational Sciences Institute (CCTSI) In the News

5280

Inside Colorado’s Battle Against Rare Diseases

news outlet5280
Publish DateAugust 03, 2022

Melissa Haendel’s background in genetic research might be the key to coordinating rare disease information across the CU Anschutz Campus—and the world. Haendel is one of the leaders in the Colorado Clinical and Translational Sciences Institute (CCTSI).

Full Story
9News

Q&A: Nationwide long COVID-19 study needs more participants

news outlet9News
Publish DateAugust 03, 2022

A CCTSI study looking at the long-term side effects some patients are facing months after a positive COVID-19 test, a condition often called long COVID, is searching for more participants.

Full Story
Today

Prescription exercise?

news outletToday
Publish DateJune 06, 2022

In our new series Beyond the Scale, NBC’s John Torres reports for TODAY on a groundbreaking study at the National Institutes of Health that could help doctors prescribe personalized workout plans for patients.

Full Story
CNN

More than half of early Covid-19 patients at one hospital had symptoms two years later, study finds

news outletCNN
Publish DateMay 11, 2022

Even two years after their initial infection, the majority of people who were hospitalized with Covid-19 early in the pandemic had lingering symptoms, according to a new study that may be one of the longest and largest on record to follow people with long Covid.

Full Story
9News

CU Anschutz exhibit highlights disparities in care for LGBTQ elders

news outlet9News
Publish DateMay 01, 2022

Carey Candrian, a member of the CCTSI PACT Council, received multiple grants to work on the project titled Eye to Eye, which is on display at the Fulginiti Pavilion for Bioethics and Humanities on the CU Anschutz campus.

Full Story
STAT

Researchers test the power of machine learning to unravel long Covid’s mysteries

news outletSTAT
Publish DateApril 29, 2022

Long Covid, with its constellation of symptoms, is proving a challenging moving target for researchers trying to conduct large studies of the syndrome. As they take aim, they’re debating how to responsibly use growing piles of real-world data — drawing from the full experiences of long Covid patients, not just their participation in stewarded clinical trials.

Full Story
Technology Networks

Adjusting Diet To Prevent Breast Cancer Recurrence

news outletTechnology Networks
Publish DateFebruary 10, 2022

A collaboration between the CU Cancer Center, the Anschutz Health and Wellness Center, the Colorado NORC, and the Colorado Clinical and Translational Sciences Institute, the study will look not just at how losing weight might help breast cancer survivors prevent relapse, but if certain dietary weight-loss strategies have additional benefits when it comes to the disease.

Full Story
9News

Monoclonal antibody treatment part of state's effort to fight COVID-19

news outlet9News
Publish DateNovember 14, 2021

This type of treatment is part of the latest push from the state to keep COVID-19 patients out of the hospital.

Full Story
The Colorado Sun

The story of the historic COVID vaccine trial for kids at Children’s Hospital Colorado

news outletThe Colorado Sun
Publish DateOctober 18, 2021

An elementary school boy came to every appointment in a kid-sized lab coat, a children’s book about mRNA vaccines in his arms. Another child announced she was “helping science.” And Kaniya Smith told her friends in the fourth grade that she was taking the coronavirus vaccine to test it out for the rest of them. 

Full Story
Medical Xpress

New study reveals serious long-term complications in youth-onset type 2 diabetes

news outletMedical Xpress
Publish DateJuly 21, 2021

Phil Zeitler, MD, Ph.D., has been treating youth with type 2 diabetes for more than 20 years. He and a team of researchers published a paper today on the TODAY2 study in the New England Journal of Medicine on the long-term complications of type 2 diabetes. (TODAY stands for Treatment Options for type 2 Diabetes in Adolescents and Youth. The first phase of the study took place from 2004—2011; phase two from 2011—2020. Both studies involved more than 550 participants from across the country.)

Full Story
ScienMag

New study determines cystic fibrosis therapy is safe and effective for young children

news outletScienMag
Publish DateMay 07, 2021

Children ages two to five who have the most common form of cystic fibrosis (CF), caused by two copies of the F508 gene mutation, have not had any modulator treatments available to them until recently. A new study authored by researchers at Children’s Hospital Colorado and published May 6, 2021, in Lancet Respiratory Medicine shows that the CFTR modulator – lumacaftor/ivacaftor – can be safe and well-tolerated for this age range for up to 120 weeks, allowing younger children to begin proactive treatment of CF earlier in their lives.

Full Story
Fox 31 | Channel 2

More Coloradans should take advantage of COVID-19 treatment

news outletFox 31 | Channel 2
Publish DateApril 14, 2021

DENVER (KDVR) — As many focus on the race to get Coloradans vaccinated against COVID-19, doctors and scientists continue to work to improve treatments for those who contract the virus. Monoclonal Antibody treatment first gained attention last fall as the U.S. Food and Drug Administration issued emergency use authorization to use it to treat mild to moderate cases of COVID-19 in adults. The treatment is more widely available now, according to Dr. Adit Ginde, a University of Colorado School of Medicine faculty member.

Full Story

Colorado Clinical and Translational Sciences Institute (CCTSI) News Topics